JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 138 filers reported holding JUNO THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 2.12 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $680,000 | -54.2% | 17,700 | -54.6% | 0.23% | -43.9% |
Q1 2016 | $1,486,000 | +2.4% | 39,000 | +18.2% | 0.41% | +27.3% |
Q4 2015 | $1,451,000 | +1.9% | 33,000 | -5.7% | 0.32% | +12.2% |
Q3 2015 | $1,424,000 | +5.8% | 35,000 | -27.1% | 0.29% | -16.6% |
Q2 2015 | $1,346,000 | +64.3% | 48,000 | +255.6% | 0.34% | +56.4% |
Q1 2015 | $819,000 | -52.0% | 13,500 | -58.7% | 0.22% | -24.1% |
Q4 2014 | $1,708,000 | – | 32,700 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |